NPS Preos Fracture Reduction, Bone Mineral Density Phase III Data To Top Off Late-2004 NDA

 
• By Bridget Silverman

The company is still seeking a co-promotion partner for the osteoporosis agent. The pivotal study shows significant relative reduction in vertebral fracture risk and change in bone mineral density.

More from Archive

More from Pink Sheet